HSK-39297

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameHSK-39297
Drug Alias NameHSK39297HSK-39297
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionComplement factor B inhibitors
TargetsComplement factor B
Therapy Area/IndicationsComplement-Mediated DiseasesPurpura, Thrombocytopenic, IdiopathicHemoglobinuria, Paroxysmal +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesTibet Haisco Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTibet Haisco Pharmaceutical Co LtdSichuan Haisco Pharmaceutical Co LtdHaisco Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsComplement-Mediated DiseasesPurpura, Thrombocytopenic, IdiopathicHemoglobinuria, Paroxysmal +[11] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A